UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000020242 |
|---|---|
| Receipt number | R000023226 |
| Scientific Title | A phase III study comparing gefitinib and inserted cisplatin and pemetrexed with gefitinib as a first-line treatment for patients with advanced non-squamous non-small-cell lung cancer harboring EGFR activating mutation (JCOG1404/WJOG8214L, AGAIN study) |
| Date of disclosure of the study information | 2015/12/17 |
| Last modified on | 2021/01/05 16:04:08 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2015/12/17 10:49:26 | ||
| 2 | Update | 2016/06/23 18:10:35 | Last name of lead principal investigator Last name of lead principal investigator Name of primary person or sponsor Organization Organization Organization Institutions |
|
| 3 | Update | 2021/01/05 16:04:08 | Recruitment status Date of IRB |
